Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 18 04:00PM ET
2.70
Dollar change
-0.09
Percentage change
-3.23
%
Index- P/E- EPS (ttm)-4.65 Insider Own22.26% Shs Outstand6.99M Perf Week-3.91%
Market Cap18.87M Forward P/E- EPS next Y-4.54 Insider Trans0.00% Shs Float5.44M Perf Month-71.28%
Income-30.01M PEG- EPS next Q-1.20 Inst Own35.19% Short Float2.25% Perf Quarter-56.17%
Sales0.00M P/S- EPS this Y22.56% Inst Trans-8.22% Short Ratio0.97 Perf Half Y-65.30%
Book/sh-4.07 P/B- EPS next Y-27.17% ROA-53.59% Short Interest0.12M Perf Year65.64%
Cash/sh5.87 P/C0.46 EPS next 5Y- ROE- 52W Range1.50 - 13.49 Perf YTD-56.10%
Dividend Est.- P/FCF- EPS past 5Y14.92% ROI-56.02% 52W High-79.99% Beta0.21
Dividend TTM- Quick Ratio12.57 Sales past 5Y-20.00% Gross Margin- 52W Low80.00% ATR (14)0.65
Dividend Ex-Date- Current Ratio12.57 EPS Y/Y TTM22.60% Oper. Margin0.00% RSI (14)27.85 Volatility5.47% 13.43%
Employees9 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom3.00 Target Price11.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q5.37% Payout- Rel Volume0.32 Prev Close2.79
Sales Surprise- EPS Surprise-35.23% Sales Q/Q- EarningsFeb 22 BMO Avg Volume125.67K Price2.70
SMA20-36.41% SMA50-60.13% SMA200-62.23% Trades Volume40,568 Change-3.23%
Date Action Analyst Rating Change Price Target Change
Jun-08-20Reiterated H.C. Wainwright Buy $20 → $10
May-14-20Initiated BTIG Research Buy $23
Oct-02-19Reiterated Chardan Capital Markets Buy $17
Sep-25-19Initiated Chardan Capital Markets Buy $17
Sep-18-19Initiated William Blair Outperform
May-31-19Initiated H.C. Wainwright Buy
Sep-01-17Initiated Citigroup Buy $11
Mar-06-17Resumed Jefferies Buy $17
May-12-16Resumed Jefferies Buy
Feb-27-24 08:11AM
08:00AM
06:31AM
Feb-22-24 07:41AM
07:00AM
07:47AM Loading…
Nov-07-23 07:47AM
07:30AM
Oct-20-23 01:22PM
Aug-01-23 07:40AM
07:30AM
Jun-28-23 08:30AM
Jun-09-23 09:55AM
May-18-23 12:00PM
May-15-23 09:57PM
07:40AM
07:30AM Loading…
07:30AM
May-10-23 08:00AM
May-08-23 08:30AM
May-01-23 07:00AM
Mar-10-23 02:24AM
Mar-08-23 11:12PM
07:30AM
Mar-01-23 08:30AM
Dec-29-22 10:18AM
05:30AM
Dec-28-22 08:00AM
Nov-09-22 08:00AM
Nov-02-22 08:30AM
Oct-20-22 11:28AM
Oct-17-22 09:18AM
08:51AM Loading…
08:51AM
08:30AM
Sep-26-22 09:21AM
Sep-09-22 04:05PM
Aug-31-22 06:25PM
Aug-23-22 12:38PM
Aug-22-22 08:00AM
Aug-12-22 09:55AM
Aug-09-22 08:00AM
Jun-22-22 08:58AM
May-04-22 08:30AM
Apr-07-22 09:57AM
08:30AM
Mar-21-22 09:52AM
Mar-01-22 09:05AM
07:30AM
Feb-28-22 08:30AM
Dec-01-21 07:44AM
Nov-08-21 08:45AM
07:30AM
Nov-03-21 08:30AM
Nov-01-21 08:30AM
Oct-11-21 08:30AM
Oct-01-21 07:00AM
Sep-30-21 10:32AM
08:30AM
Sep-27-21 08:30AM
Sep-08-21 08:30AM
Aug-02-21 08:55AM
07:30AM
Jul-26-21 03:01PM
08:30AM
Jun-10-21 08:30AM
Jun-04-21 05:20AM
May-28-21 08:00AM
May-19-21 06:19AM
May-17-21 07:57AM
May-13-21 09:01AM
May-12-21 02:35PM
10:03AM
08:30AM
07:30AM
07:20AM
06:59AM
06:45AM
May-11-21 04:15PM
May-05-21 05:10PM
Apr-07-21 08:46AM
Apr-05-21 09:31AM
Mar-08-21 12:30PM
07:30AM
05:30AM
Mar-06-21 10:57AM
Mar-01-21 08:30AM
Feb-08-21 02:30PM
01:20PM
12:30PM
11:30AM
11:13AM
11:00AM
09:43AM
06:20AM
12:45AM
Feb-07-21 01:12PM
10:30AM
Feb-06-21 01:10PM
10:00AM
07:15AM
Feb-05-21 09:15PM
09:00PM
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson's disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Luthringer RemyCEOMay 02 '23Sale3.763,64113,69068,994May 02 06:15 PM
Luthringer RemyCEOMay 01 '23Sale3.8523,75391,44972,635May 02 06:15 PM
Race GeoffPresidentMay 01 '23Sale3.8522,08285,01651,324May 02 06:14 PM
Ahlholm Frederick WSVP, CFO and SecretaryMay 01 '23Sale4.483,58016,03817,518May 02 06:13 PM